Stay updated on Pembrolizumab & Cetuximab in HNSCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.

Latest updates to the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page
- ChecktodayChange DetectedRevision update from v3.3.3 to v3.3.4. No substantive changes to study details or page content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now shows a consolidated Locations section for California, Michigan, and Missouri, replacing the separate California Locations, Michigan Locations, and Missouri Locations subsections; the revision is updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.4%

- Check50 days agoChange DetectedTwo minor textual edits clarify PubMed-generated publications and update the page revision from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check57 days agoChange DetectedThe government funding/operating-status notice for the NIH Clinical Center was removed from the page, a minor housekeeping change that does not affect study details or user-facing functionality.SummaryDifference0.3%

- Check72 days agoChange DetectedObserved a minor administrative update (new last update date) with no substantive changes to study design, primary/secondary outcomes, eligibility criteria, or participating locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check100 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

Stay in the know with updates to Pembrolizumab & Cetuximab in HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.